NRX Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
NRX Pharmaceuticals, Inc. (NRXP) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 2.69 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-21.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-05-21
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 2.69M shares, a 5.49% decline year-over-year.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 2.70M shares, a 3.71% decline year-over-year.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 2.72M shares, a 2.80% decline year-over-year.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 2.84M shares, a 4.38% increase year-over-year.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 2.78M shares, a 6.45% increase from fiscal 2018.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 2.61M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | 2.69M shares 10-Q · filed 2021-05-21 | |||
| 2020-09-30 | 2.70M shares 10-Q · filed 2020-11-16 | 2.71M shares derived: average of 2 quarters · filed 2020-11-16 | 2.75M shares 10-Q · filed 2020-11-16 | 2.77M shares derived: average of 4 quarters · filed 2021-05-21 |
| 2020-06-30 | 2.72M shares 10-Q · filed 2020-08-14 | 2.78M shares 10-Q · filed 2020-08-14 | 2.79M shares derived: average of 3 quarters · filed 2021-05-21 | 2.79M shares derived: average of 4 quarters · filed 2021-05-21 |
| 2020-03-31 | 2.84M shares 10-Q · filed 2021-05-21 | 2.83M shares derived: average of 2 quarters · filed 2021-05-21 | 2.82M shares derived: average of 3 quarters · filed 2021-05-21 | 2.81M shares derived: average of 4 quarters · filed 2021-05-21 |
| 2019-12-31 | 2.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | 2.81M shares derived: average of 2 quarters · filed 2020-11-16 | 2.80M shares derived: average of 3 quarters · filed 2020-11-16 | 2.78M shares 10-K · filed 2020-03-30 |
| 2019-09-30 | 2.80M shares 10-Q · filed 2020-11-16 | 2.80M shares derived: average of 2 quarters · filed 2020-11-16 | 2.77M shares 10-Q · filed 2020-11-16 | 2.74M shares derived: average of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | 2.79M shares 10-Q · filed 2020-08-14 | 2.76M shares 10-Q · filed 2020-08-14 | 2.72M shares derived: average of 3 quarters · filed 2020-08-14 | 2.70M shares derived: average of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | 2.73M shares 10-Q · filed 2020-05-15 | 2.68M shares derived: average of 2 quarters · filed 2020-05-15 | 2.66M shares derived: average of 3 quarters · filed 2020-05-15 | 2.65M shares derived: average of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | 2.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | 2.63M shares derived: average of 2 quarters · filed 2020-03-30 | 2.62M shares derived: average of 3 quarters · filed 2020-03-30 | 2.61M shares 10-K · filed 2020-03-30 |
| 2018-09-30 | 2.62M shares 10-Q · filed 2019-11-14 | 2.61M shares derived: average of 2 quarters · filed 2019-11-14 | 2.61M shares 10-Q · filed 2019-11-14 | 1.50M shares 10-Q · filed 2018-11-08 |
| 2018-06-30 | 2.61M shares 10-Q · filed 2019-08-14 | 2.60M shares 10-Q · filed 2019-08-14 | 2.36M shares derived: average of 3 quarters · filed 2019-08-14 | |
| 2018-03-31 | 2.59M shares 10-Q · filed 2019-05-15 | 2.24M shares derived: average of 2 quarters · filed 2019-05-15 | ||
| 2017-12-31 | 1.89M shares 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |